Clinial Training Courses: Colorectal Cancer: Part 1

Drs. Nicholas J. Petrelli and Brett T. Gemlo

Discuss the advantages and disadvantages of resection of the primary colon tumor in patients with unresectable stage IV colon cancer; Discuss the results of studies that look at whether a subgroup of patients with unresectable hepatic metastases from colorectal cancer could become respectable with newer chemotherapeutic agents; Utilize the current surveillance recommendations for patients with hereditary nonpolyposis colon cancer (HNPCC); Determine when prophylactic surgery is indicated for HNPCC; and Recognize the characteristics of a malignant polyp that require further resection.

Colorectal Cancer: Part 2

Drs. Patricia Robers, Frederick Greene, Philip J. Caushaj; and Edward W. Greeno

Define the probability of a pathologic complete response (pCR) after neodajuvant CRT and identify some of the factors that contribute to achieving pCR; Describe new cancer staging strategies included in and planned for the sixth and seventh editions of the American Joint Committee on Cancer (AJCC) Cancer Staging Manual; Explain the potential benefits and limitations of sentinel lymph node mapping in the management of patients with colorectal cancer; and Review the current options in chemotherapy and biologic therapy for advanced colorectal therapy for advanced colorectal cancer and choose the best regimen for patients.